key highlights for IPO:

• Overview
• Details and Timeline
• Key factor(P/E ratio)
• Company’s financial
• Objective of issue
• Personal view
• Bidding Detail
• Gmp

Overview:

Established in 2007, Shelter Pharma Limited, formerly recognized as Shelter Pharmacy, operates within the realm of manufacturing herbal products, encompassing both the Human Pharma and Veterinary sectors. As part of its growth strategy, the company is currently considering an initial public offering (IPO) to expand its reach and strengthen its position in the market. The company has gained a solid reputation for producing high-quality pharmaceutical products, ensuring the well-being of both humans and animals.

Based in Himmatnagar, Gujarat, the company is a bastion of producing herbal medicines that cater to the realms of veterinary, poultry, and human healthcare. The core philosophy driving the company is to provide cost-effective and superior solutions to the health challenges faced by both humans and animals.

Within its repertoire, Shelter Pharma Limited presents an expansive array of health supplements tailored to enhance human and poultry well-being. The company prides itself on harmonizing the principles of Ayurveda with modernity, a fusion that propels its endeavors.

Shelter Pharma’s offerings encompass a spectrum of products catering to both Human Healthcare and Veterinary Healthcare domains. Among the Human Healthcare roster, products such as Lemonade Barley Water, Sherolax, Baldeepak, and Stonyl Tablets stand out. For the Veterinary Healthcare sector, products like Agrical Powder, Lactocal Gel, and Shelodex Ultra Ointment are featured.

Notably, Shelter Pharma’s clientele primarily hails from rural and semi-urban markets, underscoring the company’s reach into communities where its products have a significant impact

Company Financials

Shelter Pharma IPO Financial Information (Restated)

Period Ended	31 Mar 2021	31 Mar 2022	31 Mar 2023
Assets	1,020.24	1,283.93	2,144.90
Revenue	2,248.86	3,005.84	3,615.51
Profit After Tax	-23.88	183.70	578.33
Net Worth	711.17	880.42	1,451.06
Reserves and Surplus	667.40	844.45	676.68
Total Borrowing	0.46	13.12	178.41

Objects of the Issue

The company intends to utilize the net fresh issue proceeds for the following objects:

a) Working capital requirements and

b) General corporate purposes.

Shelter Pharma IPO Review (I would Avoid)

• The company operates within the realm of manufacturing and marketing herbal products.
• However, the remarkable profits displayed for FY23 have raised suspicions, suggesting possible financial manipulation.
• The requested price, based on these extraordinary earnings, presents an enticing 8.4 P/E ratio.
• Nevertheless, concerns arise about the sustainability of such performance in the long term.
• Despite the initial allure of the valuation, it might be wise to consider skipping this offering due to the uncertainties surrounding it.

Shelter Pharma IPO Subscription Status (Bidding Detail)

As of August 11, 2023, at 7:02 PM, the Shelter Pharma IPO has garnered a subscription rate of:

• Overall Subscription: 3.21 times
• Retail Category Subscription: 5.62 times
• QIB (Qualified Institutional Buyers) Category Subscription: Yet to be specified
• NII (Non-Institutional Investors) Category Subscription: 0.45 times

For the latest and detailed subscription information, including Day by Day Subscription Details, please refer to the live status updates.

GMP(grey market premium)

• Shelter Pharma’s latest IPO GMP today stands at approximately ₹5(+/-) as of the latest update on August 12th, 2023, at 10:22 PM.
• Given the price band of ₹42.00, the estimated listing price for the Shelter Pharma SME IPO is around ₹47 (cap price + today’s GMP).
• This suggests an expected gain/loss per share of approximately 11.90% in terms of percentage.
• The Shelter Pharma SME IPO Retail Subject to Sauda is at ₹11,400, reflecting the dynamics of retail participation in the market.